Involvement of cytotoxic Eomes-expressing CD4 + T cells in secondary progressive multiple sclerosis
Open Access
- 8 March 2021
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (11)
Abstract
Significance: Multiple sclerosis (MS) can transition from a relapsing-remitting form (RRMS) into a chronic progressive form (secondary progressive MS, SPMS). SPMS pathogenesis remains poorly understood with diagnosis based entirely on retrospective clinical monitoring. We show that T helper cells expressing the transcription factor Eomes (Eomes + Th cells) were significantly increased in peripheral blood from SPMS patients versus healthy subjects or RRMS and other progressive MS patients. Moreover, Eomes + Th cells expressing granzyme B were found infiltrating brain tissues in SPMS autopsy samples, providing support for a pathogenic role. Analysis of clinical status on follow-up indicated the value of measuring Eomes + Th cells for SPMS diagnosis and prognostic monitoring. This study may contribute to future development of biomarker-assisted “precision medicine” for MS.Keywords
Funding Information
- Japan Agency for Medical Research and Development (17ek0109097)
- Japan Agency for Medical Research and Development (17ek0109155)
- MEXT | Japan Society for the Promotion of Science (17K16135)
This publication has 56 references indexed in Scilit:
- Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff OptimizationPLOS ONE, 2012
- Granzyme B-Induced Neurotoxicity Is Mediated via Activation of PAR-1 Receptor and Kv1.3 ChannelPLOS ONE, 2012
- Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility lociAnnals of Neurology, 2011
- Analysis of biomarker data: logs, odds ratios, and receiver operating characteristic curvesCurrent Opinion in HIV and AIDS, 2010
- Evidence for a two-stage disability progression in multiple sclerosisBrain, 2010
- Impact of multiple sclerosis relapses on progression diminishes with timeNeurology, 2009
- Multiple sclerosisThe Lancet, 2008
- Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokinesProceedings of the National Academy of Sciences, 2008
- Defining the clinical course of multiple sclerosisNeurology, 1996
- Rating neurologic impairment in multiple sclerosisNeurology, 1983